)
){kind=logo}
First path. Right path.
ALEX (Allergy Xplorer) was the first ELISA based in-vitro multiplex allergy test allowing simultaneous measurements of quantitative total IgE (tIgE) and specific IgE (sIgE) against a large number of allergen extracts and molecular allergens.
ALEX³ is the third iteration of the test and comes with a panel of 300 allergens, including high-relevance allergen sources and 85 allergen families. It contains 218 molecular allergens, 107 of which are unique to the test - it is the widest range of molecular allergens on the market. ALEX³ improves the quality of diagnosis and makes individualised and evidence-based therapy possible for every patient.
)
20 Arrays
)
50 Arrays
Benefits
Complete sensitisation profile in one assay run
Identification of co- & cross-sensitisations
Accuracy of diagnosis, risk management & therapy recommendation
Combination of clinical history and test results
Elimination of clinically irrelevant antibodies (false-positive results) due to CCD blockade
Allergen panel
- ELISA-based IgE multiplex assay
- 218 molecular allergens
- 82 extracts
- 145 allergen sources
- Quantitative results for sIgE and tIgE
Comprehensive
- High-relevance allergen sources
- 85 allergen families
- 107 exclusive molecular allergens
Specific
- High specificity & sensitivty
- Accuracy of diagnosis
- Accuracy of risk management
Efficient
- First path, right path
- Interpretation guide available
- Automated processing systems
)
 "WEB_MADx_Case-Study_ANNA - quadrat")
)
)
){kind=logo}
)
){kind=logo}
)
)